The performance of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key regions has introduced considerable volatility. Investors are now assessing the impact of gener